ICMR-NIN Study Links Vitamin D, B-Complex Deficiencies to 40% Higher Dementia Risk in Indian Adults

India Gets First Disease-Modifying Alzheimer's Drug Leqembi After CDSCO Nod

Eisai's Leqembi (lecanemab), India's first disease-modifying therapy for early Alzheimer's, has been launched after CDSCO approval. This marks a shift from symptomatic to disease-modifying treatment, but challenges of early diagnosis, biomarker infrastructure, and affordability remain significant.

Proposed Patient Data Collective (PDC) Model for Rare Diseases in India Inspired by Amul Cooperative

A new proposal suggests creating a Patient Data Collective (PDC) for rare diseases in India, modeled on the Amul dairy cooperative. This collective would pool patient data to accelerate drug discovery and clinical trials, addressing the challenge of small patient populations for rare diseases.

SC Pushes FSSAI for Front-of-Pack Warning Labels; Expert Flags 'Two or More' Threshold Loophole

FSSAI has proposed red hexagonal warning labels for packaged foods high in sugar, salt, or saturated fat, but a critical loophole exists: warnings are triggered only when a product is high in two or more of these nutrients. This allows many unhealthy products to escape scrutiny. The Supreme Court is monitoring the issue with the next hearing on September 10, 2026. For exams, this is relevant to food safety regulation, consumer rights, and judicial activism.

Climate Change: 145 Million Indian Children (0-9) Face Heat Stress Risk, VUB Study Warns

A new study reveals that human-induced climate change has pushed 145 million Indian children (aged 0-9) into at least one additional month of dangerous heat stress annually, making them vulnerable to dehydration, heatstroke, and developmental issues. The findings highlight the disproportionate impact on children, especially from low-income families, and call for urgent emission cuts aligned with the Paris Agreement.

ICMR Study: 61% Gram-Negative Infections Carbapenem-Resistant; Mortality 39-51%

A large ICMR study across 20 Indian hospitals (2022-2025) reveals that carbapenem-resistant Gram-negative infections cause significantly higher mortality (39-51% in bloodstream infections) and cost 1.1-2 times more to treat. The study stresses that antimicrobial resistance is a complex interplay of healthcare transmission, antibiotic pressure, and diagnostic gaps, not just antibiotic overuse.

Candida auris Shows 90% Azole Resistance; Study Reveals Gene Duplication & Eagle Effect Challenging Antifungals

Fungal infections are rising due to global warming, with Candida auris emerging as a multidrug-resistant threat (30-40% mortality). New research from JNCASB and collaborators reveals that C. auris uses gene duplication (Erg11) and mutations (Fks1) to resist antifungals, and also exhibits the 'Eagle effect' where high drug doses paradoxically trigger compensatory chitin production, making the pathogen survive. This signals the end of the chemical arms race approach and calls for combination therapies and revised susceptibility testing limits.

MeitY Summons Meta Global Team Over Algorithmic Bias; Parliamentary Panel to Question

Government summons Meta's global team to clarify algorithmic bias and role in public order after MeitY rejects technical glitch explanation. Parliamentary panel will also question the company. This highlights growing regulatory scrutiny on social media algorithms and their societal impact.

WHO's IARC Classifies Hydrochlorothiazide, Voriconazole, Tacrolimus as Group 1 Carcinogens

Three widely used medicines for hypertension, fungal infections, and transplant rejection have been classified as Group 1 carcinogens by WHO's IARC. Patients are warned not to discontinue treatment without consulting doctors, as the classification identifies hazard, not real-world risk at prescribed doses.